Association Between XPD Lys751Gln and Asp312Asn Polymorphisms and Hepatocellular Carcinoma Risk A Systematic Review And Meta-Analysis

被引:12
|
作者
Peng, Qiliu [1 ]
Li, Shan [1 ]
Lao, Xianjun [1 ]
Chen, Zhiping [2 ]
Li, Ruolin [3 ]
Qin, Xue [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning 530021, Guangxi, Peoples R China
[2] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning 530021, Guangxi, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Res, Nanning 530021, Guangxi, Peoples R China
关键词
DNA-REPAIR GENES; HEPATITIS-B; XERODERMA-PIGMENTOSUM; LUNG-CANCER; XRCC1; ERCC2; METAANALYSIS; DAMAGE; HETEROGENEITY; PHENOTYPES;
D O I
10.1097/MD.0000000000000330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genetic polymorphisms of xeroderma pigmentosum group D (XPD) in the nucleotide excision repair pathway may influence cancer susceptibility by affecting the capacity for DNA repair. Studies investigating the association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma (HCC) risk reported inconsistent results. The aim of this study was to quantitatively summarize the evidence for such an association. Eligible studies were identified by searching electronic databases including PubMed, Embase, Cochrane library, and CBM, Chinese Biomedical Literature Database, for the period up to October 2014. The association of XPD Lys751Gln and Asp312Asn polymorphisms and HCC risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs). Finally, a total of 11 studies with 4322 cases and 4970 controls were included for XPD Lys751Gln polymorphism and 6 studies with 2223 cases and 2441 controls were available for XPD Asp312Asn polymorphism. With respect to XPD Lys751Gln polymorphism, statistically significant increased HCC risk was found when all studies were pooled into the meta-analysis (Gln/Gln vs Lys/Lys: OR = 1.363, 95% CI 1.065-1.744, P = 0.014; Lys/Gln vs Lys/Lys: OR = 1.205, 95% CI 1.099-1.321, P = 0.000; Gln/Gln_Lys/Gln vs Lys/Lys: OR = 1.300, 95% CI 1.141-1.480, P = 0.000). In subgroup analyses by ethnicity, source of control, Hardy-Weinberg equilibrium (HWE) in controls, hepatitis B virus (HBV) infection, and statistically significant increase of HCC risk was found in East Asians, population-based studies, studies consistent with HWE, and HBV-positive subjects, but not in mixed/ other populations, hospital-based studies, studies deviating from HWE, and HBV-negative subjects. With respect to XPD Asp312Asn polymorphism, no significant association with HCC risk was found in the overall and subgroup analyses. The results suggest that the XPD Lys751Gln polymorphism contributes to increased HCC susceptibility, especially in East Asian populations. Further, large and well-designed studies are required to validate this association.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] XPD Lys751Gln and Asp312Asn polymorphisms and bladder cancer risk: a meta-analysis
    Li, Chunxiang
    Jiang, Zheng
    Liu, Xinghan
    MOLECULAR BIOLOGY REPORTS, 2010, 37 (01) : 301 - 309
  • [2] XPD Lys751Gln and Asp312Asn polymorphisms and bladder cancer risk: a meta-analysis
    Chunxiang Li
    Zheng Jiang
    Xinghan Liu
    Molecular Biology Reports, 2010, 37 : 301 - 309
  • [3] XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: A meta-analysis
    Yan, Yulan
    Liang, Hongjie
    Light, Morning
    Li, Taijie
    Deng, Yan
    Li, Meng
    Li, Shan
    Qin, Xue
    TUMOR BIOLOGY, 2014, 35 (03) : 1907 - 1915
  • [4] Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case–control studies
    Ying Zhang
    Dapeng Ding
    Xiaoxue Wang
    Zhenglan Zhu
    Meiyan Huang
    Xiaofeng He
    International Journal of Colorectal Disease, 2011, 26 : 1257 - 1264
  • [5] Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies
    Zhang, Ying
    Ding, Dapeng
    Wang, Xiaoxue
    Zhu, Zhenglan
    Huang, Meiyan
    He, Xiaofeng
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2011, 26 (10) : 1257 - 1264
  • [6] Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer
    Noel Pabalan
    Ofelia Francisco-Pabalan
    Lillian Sung
    Hamdi Jarjanazi
    Hilmi Ozcelik
    Breast Cancer Research and Treatment, 2010, 124 : 531 - 541
  • [7] Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer
    Pabalan, Noel
    Francisco-Pabalan, Ofelia
    Sung, Lillian
    Jarjanazi, Hamdi
    Ozcelik, Hilmi
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (02) : 531 - 541
  • [8] Association Between the Asp312Asn, Lys751Gln, and Arg156Arg Polymorphisms in XPD and the Risk of Prostate Cancer
    Fu, Weijin
    Xiao, Feifan
    Zhang, Ruoheng
    Li, Jiatong
    Zhao, Dong
    Lin, Xuandong
    Xu, Yanzhen
    Song, Xiaowei
    Xie, Zhibin
    Wen, Qiongxian
    Yang, Xiaoli
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2017, 16 (06) : 692 - 704
  • [9] XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma susceptibility: A meta-analysis of 11 case-control studies in an Asian population
    Yang, Qi
    Wei, Yan-Fei
    Zhang, Yuan
    Huang, Guang-Mei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (06) : 2406 - 2414
  • [10] ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis
    Bo Chen
    Yong Zhou
    Ping Yang
    Xiao-Ting Wu
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 939 - 946